COMMUNIQUÉS West-GlobeNewswire

Cannara Biotech Achieves its Highest National Market Share of 3.2% in July 2024 and Announces Investor Webcast Scheduled for August 20, 2024
16/08/2024
MONTREAL, Aug. 16, 2024 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (" Cannara " or the " Company ") ( TSXV: LOVE ) ( OTCQB: LOVFF ) ( FRA: 8CB0 ), a vertically integrated producer of premium-grade cannabis and derivative [...]
Safety Shot Releases Second Quarter 2024 Results and Corporate Highlights
16/08/2024
- Q2 Revenues Increased 40% - Q2 Operating Expenses Decreased 17.7% - Recent Clinical Trial Confirms Dramatic Reduction of Blood Alcohol Content - Revolutionary Formula to be Soon Released in Convenient 4-ounce Bottles [...]
HealthLynked Corp. Announces Second Quarter and First Half 2024 Results: Continued Cost Reductions Set the Stage for Strategic Shift to App-Based Technology Services
16/08/2024
NAPLES, Fla., Aug. 16, 2024 (GLOBE NEWSWIRE) -- via IBN -- HealthLynked Corp. ( OTCQB: HLYK ), a leading provider of healthcare networking and technological innovation, has reported its financial results for the three- [...]
InnovAge PACE Celebrates Anniversary of Vibrant Sacramento Center
16/08/2024
PACE Program Provides Highly Coordinated Personalized Senior Care in Partnership with Eskaton and Adventist Health SACRAMENTO, Calif., Aug. 16, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge”) (Nasdaq: INNV [...]
AIM ImmunoTech Reports Second Quarter 2024 Financial Results and Provides Corporate Update
16/08/2024
– Continued execution across Ampligen® clinical development programs and growing body of positive data in multiple high-value indications – Company to host conference call and webcast today, August 16 th at 8:30 AM ET [...]
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
16/08/2024
WATERTOWN, Mass., Aug. 16, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious [...]
Tonix Pharmaceuticals Provides Update on the Development of Its Single Dose Live Attenuated Virus Vaccine Candidate for Mpox, TNX-801, as WHO Declares Mpox Outbreak a Global Health Emergency
16/08/2024
World Health Organization (WHO) has declared spread of mpox in multiple African countries a public health emergency of international concern (PHEIC) 1 Tonix’s live virus vaccine candidate, TNX-801, is designed to [...]
Sol-Gel Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
16/08/2024
Following recent transactions and cost-cutting efforts, Sol-Gel’s cash runway is expected to extend into the first quarter of 2026 Ongoing Phase 3 clinical trial of SGT-610 for Gorlin Syndrome with over 30 clinical [...]
Pfizer and BioNTech Provide Update on mRNA-based Combination Vaccine Program Against Influenza and COVID-19 in Individuals 18-64 Years of Age
16/08/2024
In a Phase 3 trial, Pfizer and BioNTech’s combination vaccine candidate against influenza and COVID-19 met one of its two primary immunogenicity objectives The trial did not meet one of its primary immunogenicity [...]
Immuron Announces New U.S. Department of Defense Research Award for Naval Medical Research Command and Walter Reed Army Institute of Research to advance Travelan®
16/08/2024
Highlights: $3.5 (USD $2.3) million funding for NMRC and WRAIR approved by the U.S. Department of Defense to advance the development of Travelan. MELBOURNE, Australia, Aug. 16, 2024 (GLOBE NEWSWIRE) -- Immuron Limited ( [...]
Vistin Pharma ASA: Invitation to Q2 2024 conference call
16/08/2024
Oslo, Norway, 16 August 2024 Vistin Pharma ASA will release its second quarter and YTD 2024 results on Friday 23 rd of August 2024. Vistin Pharma will host a conference call for all shareholders and interested parties [...]
Aino Health AB (publ): interim report january-june 2024
16/08/2024
This document in English is a translation of the original in Swedish. In case of any discrepancy, the Swedish original will prevail. Extending contracts. Improved cash flow. January – June 2024 • Net sales were KSEK 12 [...]
NEXSTIM PLC HALF-YEAR REPORT JANUARY 1 – JUNE 30, 2024 (UNAUDITED)
16/08/2024
Company announcement, Helsinki, August 16, 2024 at 9 am (EEST) NEXSTIM PLC HALF-YEAR REPORT JANUARY 1 – JUNE 30, 2024 (UNAUDITED) NEXSTIM CONTINUED TO GROW AND IMPROVED ITS PROFITABILITY IN THE FIRST HALF OF THE YEAR [...]
Bavarian Nordic Submits Data to EMA to Extend Mpox/Smallpox Vaccine Approval to Adolescents
16/08/2024
Interim results from clinical study show non-inferiority of immune responses from mpox/smallpox vaccination in adolescents and similar safety profile compared to adults, supporting the extension of current approval in [...]
Immuron CEO, Steven Lydeamore to present at the Emerging Growth Conference
16/08/2024
MELBOURNE, Australia, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to announce that our Chief Executive [...]
Precipio Announces Q2-2024 Shareholder Update Call
15/08/2024
Conference Call to be held on August 19, 2024 at 5:00 PM EDT NEW HAVEN, Conn., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , will be hosting its Q2-2024 corporate [...]
Aptose Announces Adjournment of its Special Meeting of Shareholders
15/08/2024
SAN DIEGO and TORONTO, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing highly differentiated oral [...]
Alvotech Reports Record Revenues and Adjusted EBITDA for the Second Quarter and First Six Months of 2024
15/08/2024
Record Total Revenues of $236 million for the first six months of 2024, an over ten-fold increase compared to same period in 2023 Product revenues for the first six months were $66 million, a 190% increase from the same [...]
Alvotech Reports Record Revenues and Adjusted EBITDA for the Second Quarter and First Six Months of 2024
15/08/2024
Record Total Revenues of $236 million for the first six months of 2024, an over ten-fold increase compared to same period in 2023 Product revenues for the first six months were $66 million, a 190% increase from the same [...]

Pages